NCT07293559

Brief Summary

IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the study is to explore infant feeding preferences, practices, and outcomes among mothers with HIV and their families in the United States. It will employ both qualitative and quantitative research methods to address existing knowledge gaps and to understand the clinical, behavioral, and social factors influencing infant feeding decisions. As part of the study's mixed method approach, a longitudinal cohort study of mothers and their infants will be established. The study also aims to pilot a national registry of breastfeeding women living with HIV in the United States.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,150

participants targeted

Target at P75+ for all trials

Timeline
61mo left

Started Feb 2026

Longer than P75 for all trials

Geographic Reach
1 country

11 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Feb 2026Apr 2031

First Submitted

Initial submission to the registry

December 16, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

February 24, 2026

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2031

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2031

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

5.2 years

First QC Date

December 16, 2025

Last Update Submit

March 25, 2026

Conditions

Outcome Measures

Primary Outcomes (12)

  • CA 1: Factors influencing infant feeding decision

    Qualitative themes from in-depth interviews

    Within 28 days and 2 years of Enrollment

  • CA 1: Infants born to women with HIV who receive any breast milk

    Binomial outcome from site level surveys

    Monthly, through study completion, up until 5 years

  • CA 2: Infant feeding method chosen

    Binary outcome

    At 48 weeks post birth

  • CA 2: Breastfeeding initiation among those who intended to breastfeed

    Binary outcome

    At 48 weeks post birth

  • CA 2: Duration of breastfeeding among PPWH who breastfeed

    Numerical outcome

    Through 96 weeks post birth

  • CA 2: Completion of intended duration of breastfeeding

    Binary outcome

    Through 96 weeks post birth

  • CA 2: Mixed method analysis of infant feeding practices from in-depth interviews and survey data

    Descriptive joint display table, with qualitative key themes and quantitative findings

    At 48 weeks post birth

  • CA 2: Breast milk samples with detectable HIV DNA or RNA

    Binary outcome

    Through 48 weeks post birth; At weaning up to 96 weeks post birth

  • CA 2: Viral load measured in different breast milk compartments

    Numerical outcome

    Through 48 weeks post birth; At weaning up to 96 weeks post birth

  • CA 3: Data completed in registry

    Binary outcome; whether specified percentage of data is completed in registry

    Through study completion, an average of 3 years

  • CA 3: Median score on Feasibility of Intervention Measure, Acceptability of Intervention Measure and Appropriateness of Intervention Measures

    Numerical outcome

    Through study completion, an average of 3 years

  • CA 3: Completion of two visit entries for at least three eligible participants

    Binary outcome; whether sites complete entries

    Through study completion, an average of 3 years

Secondary Outcomes (12)

  • CA 1: Approaches to support infant feeding decisions and improve quality of care

    Within 28 days and 2 years of Enrollment

  • CA 1: Descriptive results of current practices, burden, benefits and resources

    Monthly, through study completion, up to 5 years

  • CA 2: Median cost per postpartum woman with HIV and infant pair

    Through study completion, up to 5 years

  • CA 2: Cost effectiveness ratio presented as cost per quality adjusted life year saved in breastfeeding mother/infant pair

    Through study completion, up to 5 years

  • CA 2: Cost per case of medical condition prevented by breastfeeding

    Through study completion, up to 5 years

  • +7 more secondary outcomes

Study Arms (3)

Core Activity 1

This core activity aims to explore current site-level infant feeding practices and infant feeding decision-making and preferences at selected sites in the US.

Other: No intervention provided in this study

Core Activity 2

This core activity aims to examine infant feeding practices and outcomes among women with HIV at selected sites in the US and to describe the financial implications of different infant feeding choices.

Other: No intervention provided in this study

Core Activity 3

This core activity aims to pilot and assess the feasibility and acceptability of a national registry of breastfeeding women with HIV in the US.

Other: No intervention provided in this study

Interventions

None; No intervention provided in this study

Core Activity 1Core Activity 2Core Activity 3

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant and postpartum women with HIV (PPWH); healthcare providers (HCP) and ancillary healthcare professionals (AHP) who care for PPWH and/or their infants; other influential individuals who contribute to infant feeding decisions. Pilot registry testers who will enter data into the pilot registry.

You may qualify if:

  • Is of legal age or circumstance to provide independent informed consent
  • Belongs to one of the following five categories:
  • Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is considering breastfeeding
  • Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is not considering breastfeeding
  • Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, did not breastfeed for any duration and has no intent to breastfeed
  • Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, breastfed for less than four weeks, and has weaned
  • Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, and breastfed for four weeks or longer
  • Diagnosed with HIV prior to or during the pregnancy
  • If preferred language is other than English, is willing to participate in interviews with an available translator.
  • Is of legal age or circumstance to provide independent informed consent
  • Is a healthcare provider who self-identifies as an obstetrician, midwife, nurse, adult or pediatric infectious disease specialist, or advance practice provider who participated in the care of at least five PPWH and/or their infants over the three years prior to entry OR
  • Is an ancillary healthcare professional who self-identifies as a social worker, lactation support provider, patient navigator, pharmacist, doula who participated in the care of at least five PPWH and/or their infants over the three years prior to entry
  • Has been identified by a PPWH enrolled in Core Activity 1 as aware of her HIV status and contributing to her infant feeding decisions
  • Is of legal age or circumstance to provide independent informed consent
  • If preferred language is other than English, is willing to participate in interviews with an available translator.
  • +11 more criteria

You may not qualify if:

  • Has any condition identified during the screening period that, in the opinion of site investigator, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

University of Southern California (CRS 5048)

Los Angeles, California, 90089, United States

NOT YET RECRUITING

David Geffen School of Medicine at UCLA (CRS 5112)

Los Angeles, California, 90095, United States

NOT YET RECRUITING

University California, San Diego (CRS 4601)

San Diego, California, 92103, United States

NOT YET RECRUITING

University of Colorado, Denver (CRS 5052)

Aurora, Colorado, 80045, United States

RECRUITING

University of Florida (5051)

Jacksonville, Florida, 32209, United States

NOT YET RECRUITING

Univ of Miami Pediatric/Perinatal HIV/AIDS (5127)

Miami, Florida, 33136, United States

NOT YET RECRUITING

5030, Emory University School of Medicine Clinical Research Site

Atlanta, Georgia, 30322, United States

NOT YET RECRUITING

Lurie Children's Hospital of Chicago (CRS 4001)

Chicago, Illinois, 60614, United States

RECRUITING

Johns Hopkins University (CRS 5092)

Baltimore, Maryland, 21287, United States

NOT YET RECRUITING

Jacobi Med. Ctr. Bronx NICHD CRS (5013)

The Bronx, New York, 10461, United States

NOT YET RECRUITING

St. Jude Childrens Research Hosp, Memphis (6501)

Memphis, Tennessee, 38105, United States

NOT YET RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Core Activity 2 participants will be asked whether they agree to storage and future research testing of breastmilk specimens. Human genetic testing of leftover specimens is optional and may be declined.

MeSH Terms

Conditions

Breast Feeding

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Lisa Abuogi

    University of Colorado, Denver

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2025

First Posted

December 19, 2025

Study Start

February 24, 2026

Primary Completion (Estimated)

April 24, 2031

Study Completion (Estimated)

April 24, 2031

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie results in the publication, after deidentification.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 3 months following publication and available throughout period of funding of the International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT)
Access Criteria
* With whom? Researchers who provide a methodologically sound proposal for use of the data that is approved by the IMPAACT Network and CDC. * For what types of analyses? To achieve aims in the proposal approved by the IMPAACT Network and CDC. * By what mechanism will data be made available? Researchers may submit a request for access to data using the IMPAACT "Data Request" form at: https://www.impaactnetwork.org/studies/submit-research-proposal. Researchers of approved proposals will need to sign an IMPAACT Data Use Agreement before receiving the data.

Locations